Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Express Scripts
Moodys
Colorcon
Boehringer Ingelheim

Last Updated: November 14, 2019

DrugPatentWatch Database Preview

Perrigo R And D Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for PERRIGO R AND D, and what generic and branded alternatives to PERRIGO R AND D drugs are available?

PERRIGO R AND D has forty-two approved drugs.



Summary for Perrigo R And D
US Patents:0
Tradenames:26
Ingredients:23
NDAs:42

Drugs and US Patents for Perrigo R And D

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo R And D FAMOTIDINE famotidine TABLET;ORAL 077352-001 Jul 27, 2005 AB RX No No   Start Trial   Start Trial
Perrigo R And D OMEPRAZOLE MAGNESIUM omeprazole magnesium TABLET, DELAYED RELEASE;ORAL 204152-001 Jul 30, 2015 OTC No No   Start Trial   Start Trial
Perrigo R And D ESOMEPRAZOLE MAGNESIUM esomeprazole magnesium CAPSULE, DELAYED RELEASE;ORAL 207193-001 Aug 18, 2017 OTC No No   Start Trial   Start Trial
Perrigo R And D LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride SUSPENSION;ORAL 091292-001 May 20, 2011 OTC No No   Start Trial   Start Trial
Perrigo R And D CETIRIZINE HYDROCHLORIDE HIVES cetirizine hydrochloride TABLET;ORAL 078336-004 Dec 27, 2007 OTC No No   Start Trial   Start Trial
Perrigo R And D GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE dextromethorphan hydrobromide; guaifenesin TABLET, EXTENDED RELEASE;ORAL 207602-001 Mar 5, 2018 OTC No No   Start Trial   Start Trial
Perrigo R And D POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 090685-001 Oct 6, 2009 OTC No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Medtronic
Baxter
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.